Harris Nesbitt, the U.S. investment banking arm of BMO Financial Group, is proud to present its 4th annual conference on the Healthcare industry starting on Wednesday, December 8 at 8:00 a.m. at The Metropolitan Club in New York City.
The institutional investor event brings together more than 50 leading and emerging companies in the pharmaceutical, biotechnology, life sciences and medical technology industries. Hosted by Harris Nesbitt equity research analysts John Boris (pharmaceuticals), Thomas Shrader (biotechnology) and Joanne Wuensch (medical technologies and devices), the event features a unique mix of company presentations followed by an interactive question and answer period.
All presentations will be webcast live and can be accessed at:
www.harrisnesbitt.com/conferences/healthcare2004
Scheduled presenters and times are*:
Time
|
Track 1
|
Track 2
|
Track 3
|
Track 4
|
Track 5
|
8:00 a.m.
|
Nabi Biopharmaceuticals (NABI)
Mark Smith, SVP Finance, Treasurer & CFO
|
Stryker (SYK)
John Brown, Chairman & CEO
|
Medtronic (MDT)
Rachel Scherer, VP, IR
|
Curis (CRIS) Daniel, Passeri, President & CEO
Michael Gray, VP Finance & CFO
|
LCA Vision (LCAV)
Alan Buckey, EVP, Finance
|
8:45
|
Dyax (DYAX)
Henry Blair, Chairman, President & CEO
|
St. Jude Medical (STJ)
Laura Merriam, Director, IR
|
Inhibitex (INHX)
Joseph Patti, VP, Preclinical Dev., CSO
Russell Plumb, CFO & VP of Finance & Admin
|
Integra LifeSciences (IART)
Gerry Carlozzi, EVP & COO
|
CryoCath Technologies (CYT)
Steven Arless, President & CEO
|
9:30
|
Genzyme (GENZ)
Elliot Hillback, SVP Corp. Affairs
|
Alcon (ACL)
Kurtis Klein, VP, General Manager Consumer Products Div.
|
Oscient (OSCI)
Steven Rauscher, CEO & President
|
Cortex Pharmaceuticals
(COR)
Roger Stoll, Chairman, President & CEO
|
Aphton (APHT)
Patrick Mooney, President & CEO
|
10:15
|
Alexion (ALXN)
Lenny Bell, CEO
|
Discovery Labs (DSCO)
Robert Capetola, President & CEO
|
ArthroCare (ARTC)
Michael Baker, President & CEO
Fernando Sanchez, SVP & CFO
|
Conceptus (CPTS)
Gregory Lichtwardt, EVP, Treasurer & CFO
|
Kosan (KOSN)
Robert Johnson, Jr. EVP, Development & Chief Medical Officer
|
Time
|
Track 1
|
Track 2
|
Track 3
|
Track 4
|
Track 5
|
11:00
|
Gilead Sciences (GILD)
Mark Perry, Sr. Business Advisor
|
Zimmer (ZMH)
Raymond Elliott, Chairman, President & CEO
|
Advanced Medical Optics (AVO)
Russ Trenary, Corp. VP & Chief Marketing Officer
Sheree Aronson, VP Corp. Comm & IR
|
Northfields Labs (NFLD)
Steven Gould, Chairman & CEO
|
Praecis (PRCS)
Kevin McLaughlin, President, COO & Director
|
11:45
|
Vertex (VRTX)
Ian Smith, SVP & CFO
|
Eyetech (EYET)
David Guyer, CEO
|
ResMed (RMD)
David Pendarvis, VP Global General Counsel
|
CardioDynamics (CDIC)
Michael Perry, CEO & Director
|
AMN Healthcare (AHS)
Susan Nowakowski, President & COO
|
12:30
|
Tercica (TRCA)
Tim Lynch, CFO
Ross Clark, CTO and Founder
|
Cubist (CBST)
Mike Bonney, President & CEO
|
Respironics (RESP)
John Miclot, President & CEO
Dan Bevevino, VP & CFO
|
Oxigene
Frederick Driscoll, President & CEO
|
Keryn Biopharmaceuticals Inc.
Michael Weiss, Chairman & CEO
|
1:15
|
Vicuron (MICU)
Dov Goldstein, EVP, Finance & CFO
|
TriPath Imaging (TPTH)
Stephen Hall, CFO & SVP
|
QLT (QLTI)
Mohammed Azab, EVP Research & Development & CMO
|
Allied Healthcare (AHCI)
Sarah Eames, EVP
|
Indevus (IDEV)
Michael Rogers, EVP & CFO
|
2:00
|
Chiron (CHIR)
Joel Jung, VP & Treasurer
|
Mannkind (MNKD)
Hakan Edstrom, President, COO & Director
|
Bausch & Lomb (BOL)
Stephen McCluski, SVP & CFO
Barbara Kelley, Director, IR
Daniel Ritz, Director, IR
|
Vivus (VVUS)
Leland Wilson, President & CEO
Timothy Morris, VP of Finance & CFO
|
Emisphere Technologies (EMIS)
Michael Goldberg, CEO
|
2:45
|
InterMune (ITMN)
Norman Halleen, SVP Finance & CFO
Steven Porter, SVP Clinical Affairs
|
AVANT Immunotherapeutics
Avery Caitlin, SVP & CFO
|
AnorMED (AOM)
Michael Abrams,
President & CEO
|
Cross Country (CCRN)
Joseph Boshart, President & CEO
Howard Goldman, Director, IR
|
Concept Therapeutics (CORT)
Fred Kurland, CFO
|
*Agenda subject to change.
About Harris Nesbitt
Harris Nesbitt is an investment and corporate bank offering clients access to a full range of products and services including investment and corporate banking, treasury services, market risk management, institutional investing and research. Harris Nesbitt is part of Harris, an integrated financial services organization providing more than 1.5 million personal, business, corporate and institutional clients with banking, lending, investing and financial management solutions. Harris is a member of BMO Financial Group (NYSE, TSX: BMO). For more information, please visit www.harrisnesbitt.com.
- 30 -